Back |
home / stock / slgl / slgl message board
Subject | By | Source | When |
---|---|---|---|
Thanks Midas for starting the mb here. As I | Amatuer17 | investorshub | 04/14/2020 9:55:44 AM |
Sol-Gel Technologies Reports Full Year 2019 Financial Results | midastouch017 | investorshub | 04/14/2020 7:45:22 AM |
News, Short Squeeze, Breakout and More Instantly...
Sol-Gel Technologies Ltd. Company Name:
SLGL Stock Symbol:
NASDAQ Market:
NESS ZIONA, Israel, May 28, 2024 (GLOBE NEWSWIRE) -- Sol-Gel Technologies, Ltd. (NASDAQ: SLGL), a dermatology company, pioneering treatments for patients with severe skin conditions, conducting a Phase 3 clinical trial of SGT-610 (patidegib gel, 2%) for Gorlin syndrome, and with two approved ...
Phase 3 clinical trial of SGT-610 for Gorlin Syndrome with the first patient screened, is ongoing. Sol-Gel and Beimei Pharma announced an Asset Purchase Agreement to commercialize TWYNEO ® in China, Hong Kong, Macau, Taiwan and Israel, for a total consideration of up to $ 1 1...